An Overview of Modeling & Simulation in Healthcare
Learn what computational modeling and simulation means for the healthcare industry. We’ll calculate the benefits and expected return on investment in this upcoming webinar.
Venue:
Virtual
Watch Presentation
About this Webinar
Knowing that by 2025, 25% of all new pharmaceuticals will use in silico technology andconscious that by 2030, in silico methods will enable 60% more new drugs, the British authorities, industry, and scientific leaders are encouraging the digital transformation of the healthcare industry. Let’s take a few minutes to understand better what computational modeling and simulation mean for the healthcare industry and how they are deployed to provide more time-effective, cost-effective, and environmentally friendly solutions.
We’ll demonstrate the value of combining data with tools to help you narrow down materials options and to ensure the use of approved traceable company data.
What You Will Learn
- What are in silico methods for the healthcare industry
- What are expected benefits and the typical return on investment (ROI)
- How to deploy modeling and simulation to accelerate and amplify pharmaceutical innovation
Speakers
Luke Cox, Senior Account Manager and Thierry Marchal, EMEA Chief Technologist Healthcare